5-4-MORPHOLIN-2-YLMETHYLAMINO-5-(TRIFLUOROMETHYL)-2-PYRIDYLAMINOPYRAZINE-2-CARBONITRILE, THERAPEUTIC USES THEREOF

摘要

FIELD: chemistry.;SUBSTANCE: invention relates generally to a compound of the following formula; , ;as well as to pharmaceutical compositions containing such compounds, and the use of such compounds for inhibiting the kinase function of CHK1 and for treating CHK1 mediated diseases and conditions.;EFFECT: technical result: obtaining novel compounds, suitable for the treatment of proliferative diseases, such as cancer, by inhibiting the kinase function of CHK1.;26 cl, 7 tbl